Cyclo Therapeutics

+$0.09 (+4.50%) As of 5:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYTH and other ETFs, options, and stocks.

About CYTH

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease.

CEO
Nathan Scott Fine
Employees
9
Headquarters
Gainesville, Florida
Founded
1990

CYTH Key Statistics

Market cap
17.59M
Price-Earnings ratio
—
Dividend yield
—
Average volume
14.95K
High today
$2.10
Low today
$2.06
Open price
$2.08
Volume
3.09K
52 Week high
$13.00
52 Week low
$1.88

CYTH Earnings

-$1.68
-$1.12
-$0.56
-$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.31 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure